{"id":1067,"date":"2021-12-24T10:00:56","date_gmt":"2021-12-24T01:00:56","guid":{"rendered":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/derma\/?p=1067"},"modified":"2021-12-24T14:25:26","modified_gmt":"2021-12-24T05:25:26","slug":"2020%e5%b9%b4%e6%a5%ad%e7%b8%be%e3%80%80%e7%9a%ae%e8%86%9a%e7%a7%91%e5%ad%a6%e5%88%86%e9%87%8e","status":"publish","type":"post","link":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/derma\/office\/publications\/1067\/","title":{"rendered":"2020\u5e74\u696d\u7e3e\u3000\u76ae\u819a\u79d1\u5b66\u5206\u91ce"},"content":{"rendered":"

\u8457\u66f8<\/h1>\n

1)\u5929\u91ce \u6b63\u5b8f\u3000\u7dcf\u7de8\u96c6\uff1a\u5c71\u53e3 \u5fb9\u30fb\u4ed6\u76e3\u3000
\u81bf\u76ae\u75c7 pyoderma\u4eca\u65e5\u306e\u6cbb\u7642\u6307\u91dd 2020\u5e74\u7248 \u79c1\u306f\u3053\u3046\u6cbb\u7642\u3057\u3066\u3044\u308b\uff08\u30c7\u30b9\u30af\u7248\u3001\u30dd\u30b1\u30c3\u30c8\u7248\uff09 \u533b\u5b66\u66f8\u96622020\u5e741\u6708<\/p>\n

2)\u5929\u91ce \u6b63\u5b8f\u3000\u51fa\u5149 \u4fca\u90ce\uff0c\u795e\u90e8 \u82b3\u5247 \u7de8\u96c6
\u53e3\u8154\u7c98\u819c\u30fb\u76ae\u819a\u75c7\u72b6\u304b\u3089\u898b\u629c\u304f\u5168\u8eab\u75be\u60a3\uff0d\u30aa\u30e9\u30c9\u30ed\u30fc\u30e0\u30fb\u30c7\u30eb\u30de\u30c9\u30ed\u30fc\u30e0\uff0d \u5357\u6c5f\u5802 2020\u5e7410\u6708<\/p>\n

\u7dcf\u8aac<\/h1>\n

1)Yoshino Y, Amano M, et al. GUIDELINE Wound, pressure ulcer and burn guidelines – 6:
Guidelines for the management of burns, second edition. J Dermatol. 2020 Nov; 47(11): 1207-1235.<\/p>\n

2)Fujimoto M, Amano M, et al. GUIDELINE Wound, Pressure Ulcer and Burn Guidelines-4:
Guidelines for the Management of Connective Tissue Disease\/Vasculitis-Associated Skin Ulcers.
J Dermatol. 2020 Oct; 47(10): 1071-1109.<\/p>\n

3)Fujiwara H, Amano M, et al. Wound, pressure ulcer and burn guidelines – 2:
Guidelines for the diagnosis and treatment of pressure ulcers, second edition. J Dermatol.
2020 Sep; 47(9): 929-978.<\/p>\n

4)Hasegawa M, Amano M, et al. Wound, pressure ulcer and burn guidelines – 1:
Guidelines for wounds in general, second edition. H. J Dermatol. 2020 Aug; 47(8): 807-833.<\/p>\n

5)Kubo T, Eto H, Inoue T, Tanaka H, Amano M.
Case of accessory scrotum with hamartoma located in sacrococcygeal region: The first report J Dermatol.
2020 Jun; 47(6): e248-e249. doi: 10.1111\/1346-8138.15338. Epub 2020 Apr 4.<\/p>\n

\u75c7\u4f8b\u5831\u544a<\/h1>\n

1)\u897f\u5ddd \u967d\u592a\u90ce, \u4e45\u4fdd \u74b0, \u6d25\u5b88 \u4f38\u4e00\u90ce, \u5929\u91ce \u6b63\u5b8f\u3000
\u51a0\u52d5\u8108\u30b9\u30c6\u30f3\u30c8\u7559\u7f6e\u5f8c\u306b\u751f\u3058\u305f\u30b3\u30d0\u30eb\u30c8\u306b\u3088\u308b\u5168\u8eab\u578b\u91d1\u5c5e\u30a2\u30ec\u30eb\u30ae\u30fc: \u76ae\u819a\u75c5\u8a3a\u7642 42: 234-37, 2020 03<\/p>\n

2)Tamaki Kubo 1, Hirofumi Eto , Tomohiro Inoue , Hiroyuki Tanaka , Masahiro Amano\u3000
Case of accessory scrotum with hamartoma located in sacrococcygeal region: The first report.
J Dermatol. 2020 Jun;47(6)\uff1ae248-e249. doi:\uff1a10.1111\/1346-8138.15338<\/p>\n

3)\u4e45\u4fdd \u74b0, \u4e95\u4e0a \u77e5\u5b8f, \u5185\u7530 \u671b\u7f8e, \u4f50\u3005\u6728 \u826f\u5b50, \u6301\u7530 \u8015\u4ecb, \u9f4b\u85e4 \u6e05\u8cb4, \u5927\u77f3 \u738b,\u5b88\u6c38 \u572d\u543e,
\u6885\u5317 \u4f73\u5b50, \u76db\u53e3 \u6e05\u9999, \u4e38\u585a \u6d69\u52a9, \u5929\u91ce \u6b63\u5b8f
\u982d\u84cb\u9aa8\u6d78\u6f64\u3092\u6765\u3057\u305f\u5f8c\u982d\u90e8primary mucinous carcinoma of the skin\u306e1\u4f8b.
Skin Cancer (0915-3535)35\u5dfb1\u53f7 Page20-26\u30002020.06<\/p>\n

4)\u7d30\u4e95 \u8061\u58eb, \u6c60\u30ce\u4e0a \u5b9f, \u843d\u5408 \u6602\u4e00\u90ce, \u4e45\u4fdd \u74b0, \u6b66\u91ce \u614e\u7950, \u4f0a\u6771 \u5927\u3000
S\u72b6\u7d50\u8178\u764c\u306e\u5f8c\u8179\u819c\u7a7f\u7834\u306b\u3088\u308b\u30ac\u30b9\u58ca\u75bd\u306e\u6cbb\u7642\u7d4c\u9a13
\u5275\u50b7 (1884-880X)11\u5dfb4\u53f7 Page184-190\u30002020.10<\/p>\n

\u5b66\u4f1a\u767a\u8868<\/h1>\n

1)\u4e45\u4fdd \u74b0, \u9577\u91ce \u611b\u5b9f, \u6839\u672c \u5229\u6075\u5b50, \u4e2d\u5c71 \u6587\u5b50, \u77f3\u4e95 \u5343\u5bf8, \u5929\u91ce \u6b63\u5b8f
Scabietic leukocytoclastic vasculitis\u306e1\u4f8b\u3000\u7b2c119\u56de\u65e5\u672c\u76ae\u819a\u79d1\u5b66\u4f1a\u7dcf\u4f1a\u30002020.6\uff08WEB\uff09<\/p>\n

2)\u4e45\u4fdd \u74b0\uff0c\u6c5f\u85e4 \u535a\u6587\uff0c\u585a\u672c \u667a\u5927\uff0c\u9ed2\u6728 \u8129\u77e2\uff0c\u9577\u91ce \u611b\u5b9f\uff0c\u91ce\u4e0a \u4eac\u5b50\uff0c\u8ca1\u90e8 \u611b\u83dc\uff0c
\u897f\u5ddd \u967d\u592a\u90ce\uff0c\u5f8c\u7530 \u512a\u9999\uff0c\u8352\u6728 \u826f\u5b50\uff0c\u4e2d\u5c71 \u6587\u5b50\uff0c\u897f\u5143 \u9806\u5b50\uff0c\u91d1\u4e38 \u5fd7\u4fdd\uff0c\u6210\u7530 \u5e78\u4ee3\uff0c\u6839\u672c \u5229\u6075\u5b50\uff0c
\u9152\u4e95 \u90a6\u592b\uff0c\u6301\u7530 \u8015\u4ecb\uff0c\u6c5f\u826f \u5e78\u4e09\uff0c\u53e4\u7d50 \u82f1\u6a39\uff0c\u5929\u91ce \u6b63\u5b8f\u3000
2019\u5e74\uff081\u6708\uff5e12\u6708\uff09\u5bae\u5d0e\u5927\u5b66\u76ae\u819a\u79d1\u306e\u5165\u9662\u60a3\u8005\u7d71\u8a08\u3000\u65e5\u672c\u76ae\u819a\u79d1\u5b66\u4f1a\u7b2c156\u56de\u5bae\u5d0e\u5730\u65b9\u4f1a\u30002019.6\u5bae\u5d0e\u5e02<\/p>\n

3)\u6c5f\u85e4 \u535a\u6587\uff0c\u4e45\u4fdd \u74b0\uff0c\u585a\u672c \u667a\u5927\uff0c\u9ed2\u6728 \u8129\u77e2\uff0c\u9577\u91ce \u611b\u5b9f\uff0c\u91ce\u4e0a \u4eac\u5b50\uff0c\u8ca1\u90e8\u3000\u611b\u83dc\uff0c
\u897f\u5ddd\u3000\u967d\u592a\u90ce\uff0c\u5f8c\u7530\u3000\u512a\u9999\uff0c\u8352\u6728 \u826f\u5b50\uff0c\u4e2d\u5c71 \u6587\u5b50\uff0c\u897f\u5143 \u9806\u5b50\uff0c\u91d1\u4e38 \u5fd7\u4fdd\uff0c\u6210\u7530 \u5e78\u4ee3\uff0c\u6839\u672c \u5229\u6075\u5b50\uff0c
\u9152\u4e95 \u90a6\u592b\uff0c\u6301\u7530 \u8015\u4ecb\uff0c\u6c5f\u826f \u5e78\u4e09\uff0c\u53e4\u7d50 \u82f1\u6a39\uff0c\u5929\u91ce \u6b63\u5b8f\u3000
2019\u5e74\uff081\u6708\uff5e12\u6708\uff09\u5bae\u5d0e\u5927\u5b66\u76ae\u819a\u79d1\u306e\u5165\u9662\u60a3\u8005\u6b7b\u4ea1\u4f8b\u3068\u5370\u8c61\u306b\u6b8b\u3063\u305f\u75c7\u4f8b\u3000\u65e5\u672c\u76ae\u819a\u79d1\u5b66\u4f1a\u7b2c156\u56de\u5bae\u5d0e\u5730\u65b9\u4f1a\u30002019.6\u5bae\u5d0e\u5e02<\/p>\n

4)\u6210\u7530 \u5e78\u4ee3\uff0c\u897f\u5143 \u9806\u5b50\uff0c\u585a\u672c \u667a\u5927\uff0c\u9ed2\u6728 \u8129\u77e2\uff0c\u9577\u91ce \u611b\u5b9f\uff0c\u91ce\u4e0a \u4eac\u5b50\uff0c\u8ca1\u90e8 \u611b\u83dc\uff0c
\u897f\u5ddd \u967d\u592a\u90ce\uff0c\u6c5f\u85e4 \u535a\u6587\uff0c\u5f8c\u7530 \u512a\u9999\uff0c\u8352\u6728 \u826f\u5b50\uff0c\u4e45\u4fdd \u74b0\uff0c\u91d1\u4e38 \u5fd7\u4fdd\uff0c\u4e2d\u5c71 \u6587\u5b50\uff0c\u6839\u672c \u5229\u6075\u5b50\uff0c
\u6301\u7530 \u8015\u4ecb\uff0c\u53e4\u7d50 \u82f1\u6a39\uff0c\u5929\u91ce \u6b63\u5b8f\u3000
2019\u5e74\uff081\u6708\uff5e12\u6708\uff09\u5bae\u5d0e\u5927\u5b66\u76ae\u819a\u79d1\u306e\u5916\u6765\u60a3\u8005\u7d71\u8a08\u3000\u65e5\u672c\u76ae\u819a\u79d1\u5b66\u4f1a\u7b2c156\u56de\u5bae\u5d0e\u5730\u65b9\u4f1a\u30002019.6\u5bae\u5d0e\u5e02<\/p>\n

5)\u91d1\u4e38 \u5fd7\u4fdd\uff0c\u6210\u7530 \u5e78\u4ee3\uff0c\u897f\u5143 \u9806\u5b50\uff0c\u585a\u672c \u667a\u5927\uff0c\u9ed2\u6728 \u8129\u77e2\uff0c\u9577\u91ce \u611b\u5b9f\uff0c\u91ce\u4e0a \u4eac\u5b50\uff0c\u8ca1\u90e8 \u611b\u83dc\uff0c
\u897f\u5ddd \u967d\u592a\u90ce\uff0c\u6c5f\u85e4 \u535a\u6587\uff0c\u5f8c\u7530 \u512a\u9999\uff0c\u8352\u6728 \u826f\u5b50\uff0c\u4e45\u4fdd \u74b0\uff0c\u4e2d\u5c71 \u6587\u5b50\uff0c\u6839\u672c \u5229\u6075\u5b50\uff0c
\u6301\u7530 \u8015\u4ecb\uff0c\u53e4\u7d50 \u82f1\u6a39\uff0c\u5929\u91ce \u6b63\u5b8f\u3000
2019\u5e74\uff081\u6708\uff5e12\u6708\uff09\u5bae\u5d0e\u5927\u5b66\u76ae\u819a\u79d1\u306e\u5916\u6765\u60a3\u8005\u5831\u544a\u3000\u65e5\u672c\u76ae\u819a\u79d1\u5b66\u4f1a\u7b2c156\u56de\u5bae\u5d0e\u5730\u65b9\u4f1a\u30002019.6\u5bae\u5d0e\u5e02<\/p>\n

6)\u9577\u91ce \u611b\u5b9f\uff0c\u6c5f\u85e4 \u535a\u6587\uff0c\u6301\u7530 \u8015\u4ecb\uff0c\u5929\u91ce \u6b63\u5b8f\uff0c\u524d\u5ddd \u548c\u4e5f\uff0c\u5bae\u5d0e\u5927\uff0c\u5bae\u5d0e\u5927\u75c5\u7406\u8a3a\u65ad\u79d1\u3000
\u82e5\u5e74\u5973\u6027\u306e\u5f8c\u982d\u90e8\u306b\u767a\u751f\u3057\u305fMyxofibrosarcoma\u306e\u4e00\u4f8b\u3000\u7b2c84\u56de\u65e5\u672c\u76ae\u819a\u79d1\u5b66\u4f1a\u6771\u90e8\u652f\u90e8 \u5b66\u8853\u5927\u4f1a\u3000
2020.8\u3000\u5c71\u68a8\u5e02\uff08WEB\uff09<\/p>\n

7)\u6210\u7530 \u5e78\u4ee3\uff0c\u5f8c\u7530 \u512a\u9999\uff0c\u4e45\u4fdd \u74b0\uff0c\u91d1\u4e38 \u5fd7\u4fdd\uff0c\u5929\u91ce \u6b63\u5b8f\uff0c\u5bae\u5d0e\u5927\u3000
\u598a\u5a20\u4e2d\u306b\u5897\u60aa\u3092\u7e70\u308a\u8fd4\u3057\u305f\u6c4e\u767a\u6027\u81bf\u75b1\u6027\u4e7e\u766c\u306e1\u4f8b\u3000\u7b2c35\u56de\u65e5\u672c\u4e7e\u766c\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a\u30002020.9\u3000\u798f\u5cf6\u5e02\uff08WEB\uff09<\/p>\n

8)\u6301\u7530\u8015\u4ecb\u3000\u300c\u5404\u65bd\u8a2d\u3067\u306e\u514d\u75ab\u30c1\u30a7\u30c3\u30af\u30dd\u30a4\u30f3\u30c8\u963b\u5bb3\u5264\u306e\u4f7f\u7528\u7d4c\u9a13\u300d\u3000
Melanoma\u3000Immuno-Oncology\u3000Area\u3000Meeting\u3000in\u3000Kyushu\u30002020.9\u3000WEB<\/p>\n

9)\u5929\u91ce \u6b63\u5b8f\u3000\u6210\u4ebaT\u7d30\u80de\u767d\u8840\u75c5\/\u30ea\u30f3\u30d1\u816b\uff08ATLL\uff09-\u4e7e\u766c\u3068\u306e\u985e\u4f3c\u6027\u3068\u9451\u5225\u306b\u3064\u3044\u3066-\u3000
\u7b2c229\u56de\u65e5\u672c\u76ae\u819a\u79d1\u5b66\u4f1a\u718a\u672c\u5730\u65b9\u4f1a\u30e9\u30f3\u30c1\u30e7\u30f3\u30bb\u30df\u30ca\u30fc\u30002020.10\u3000\u718a\u672c\u5e02\uff08WEB\uff09<\/p>\n

10)\u585a\u672c \u667a\u5927\uff0c\u6301\u7530 \u8015\u4ecb\uff0c\u9577\u91ce \u611b\u5b9f\uff0c\u5f8c\u7530 \u512a\u9999\uff0c\u5929\u91ce \u6b63\u5b8f\u3000\u5bae\u5d0e\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662\u76ae\u819a\u79d1\u3000
\u814b\u7aa9\u306b\u751f\u3058\u305f\u4e73\u623f\u5916Paget\u75c5\u306e2\u4f8b\u3000\u7b2c35\u56de\u65e5\u672c\u76ae\u819a\u5916\u79d1\u5b66\u4f1a\u30002020.10\u3000\u6d66\u5b89\u5e02\uff08WEB\uff09<\/p>\n

11)\u91d1\u4e38 \u5fd7\u4fdd\uff0c\u65e5\u9ad8 \u8cb4\u5b50\uff0c\u5ddd\u53e3 \u525b\uff0c\u5929\u91ce \u6b63\u5b8f\u3000\u5bae\u5d0e\u5927\uff0c\u5bae\u5d0e\u5927\uff0c\u5bae\u5d0e\u5927\u773c\u79d1\uff0c\u5bae\u5d0e\u5927\u5185\u79d1\u3000
\u30dc\u30ea\u30b3\u30be\u30ca\u30fc\u30eb\u9577\u671f\u5185\u670d\u60a3\u8005\u306b\u751f\u3058\u305f\u591a\u767a\u6027\u5149\u7dda\u89d2\u5316\u75c7\u3001\u6709\u68d8\u7d30\u80de\u304c\u3093\u306e2\u4f8b\u3000\u7b2c72\u56de\u65e5\u672c\u76ae\u819a\u79d1\u5b66\u4f1a\u897f\u90e8\u652f\u90e8\u5b66\u8853\u5927\u4f1a\u3000
2020.10\u3000\u6771\u6e29\u5e02\uff08WEB\uff09<\/p>\n

12)\u9ed2\u6728 \u8129\u77e2\uff0c\u6301\u7530 \u8015\u4ecb\uff0c\u77f3\u4e95 \u5343\u5bf8\uff0c\u5929\u91ce \u6b63\u5b8f\u3000\u5bae\u5d0e\u5927\uff0c\u77f3\u4e95\u76ae\u819a\u79d1\u3000\u5bae\u5d0e\u770c\u5ef6\u5ca1\u5e02\u3000
\u8db3\u5e95\u306b\u751f\u3058\u305fPrimary\u3000cutaneous\u3000acral\u3000CD8+T\u3000cell\u3000lymphoma\u306e1\u4f8b\u3000
\u7b2c72\u56de\u65e5\u672c\u76ae\u819a\u79d1\u5b66\u4f1a\u897f\u90e8\u652f\u90e8\u5b66\u8853\u5927\u4f1a\u30002020.10\u3000\u6771\u6e29\u5e02\uff08WEB\uff09<\/p>\n

13)\u897f\u5143 \u9806\u5b50\uff0c\u6210\u7530 \u5e78\u4ee3\uff0c\u6885\u5317 \u90a6\u5f66\uff0c\u5929\u91ce \u6b63\u5b8f\u3000\u5bae\u5d0e\u5927\uff0c\u5bae\u5d0e\u5927\u81a0\u539f\u75c5\u611f\u67d3\u75c7\u5185\u79d1\u3000
\u5168\u8eab\u6027\u5f37\u76ae\u75c7\u3068\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u3067\u6cbb\u7642\u4e2d\u306e\u60a3\u8005\u306b\u751f\u3058\u305f\u5c16\u572d\u30b3\u30f3\u30b8\u30ed\u30fc\u30de\u3001bowenoid\u3000papulosis\u306e\u5408\u4f75\u4f8b\u3000
\u7b2c84\u56de\u65e5\u672c\u76ae\u819a\u79d1\u5b66\u4f1a\u6771\u4eac\u652f\u90e8\u5b66\u8853\u5927\u4f1a\u30002020.11\uff08WEB\uff09<\/p>\n

14\uff09\u5f8c\u7530 \u512a\u9999\uff0c\u4e2d\u6751 \u4fca\u592e\uff0c\u9577\u91ce \u611b\u5b9f\uff0c\u91ce\u4e0a \u4eac\u5b50\uff0c\u91d1\u4e38 \u5fd7\u4fdd\uff08\u5bae\u5d0e\u5927\uff09\uff0c
\u677e\u7530 \u57fa\u5f18\uff08\u540c\u81a0\u539f\u75c5\u5185\u79d1\uff09\uff0c\u9ed2\u6728 \u57fa\u6a39\uff08\u5bae\u5d0e\u5e02\uff09\uff0c\u5929\u91ce \u6b63\u5b8f\uff08\u5bae\u5d0e\u5927\uff09\u3000
\u518d\u767a\u6027\u591a\u767a\u8edf\u9aa8\u708e\u306e2\u4f8b\u3000\u65e5\u672c\u76ae\u819a\u79d1\u5b66\u4f1a\u7b2c157\u56de\u5bae\u5d0e\u5730\u65b9\u4f1a\u30002020.12\u3000\u5bae\u5d0e\u5e02\uff08WEB\uff09<\/p>\n

15\uff09\u6962\u539f \u4eae\uff0c\u6c5f\u85e4 \u535a\u6587\uff0c\u9ed2\u6728 \u8129\u77e2\uff0c\u6839\u672c \u5229\u6075\u5b50\uff0c\u5929\u91ce \u6b63\u5b8f\uff08\u5bae\u5d0e\u5927\uff09\u3000
\u8170\u90e8\u306b\u751f\u3058\u305f\u5de8\u5927\u306aChronic expanding hematoma\uff08CEH\uff09\u306e1\u4f8b\u3000\u65e5\u672c\u76ae\u819a\u79d1\u5b66\u4f1a\u7b2c157\u56de\u5bae\u5d0e\u5730\u65b9\u4f1a\u3000
2020.12\u3000\u5bae\u5d0e\u5e02\uff08WEB\uff09<\/p>\n

16\uff09\u4e2d\u6751 \u4fca\u592e\uff0c\u5f8c\u7530 \u512a\u9999\uff0c\u6c5f\u85e4 \u535a\u6587\uff08\u5bae\u5d0e\u5927\uff09\uff0c\u6d25\u5b88 \u4f38\u4e00\u90ce\uff08\u53e4\u8cc0\u7dcf\u5408\uff09\uff0c\u5929\u91ce \u6b63\u5b8f\uff08\u5bae\u5d0e\u5927\uff09
\u30a4\u30bd\u30bd\u30eb\u30d3\u30c9\u306b\u3088\u308b\u6025\u6027\u6c4e\u767a\u6027\u767a\u75b9\u6027\u81bf\u75b1\u75c7\u306e1\u4f8b\u3000\u65e5\u672c\u76ae\u819a\u79d1\u5b66\u4f1a\u7b2c157\u56de\u5bae\u5d0e\u5730\u65b9\u4f1a\u30002020.12\u3000\u5bae\u5d0e\u5e02\uff08WEB\uff09<\/span><\/p>\n

\u8b1b\u6f14<\/h1>\n

1)\u897f\u5ddd \u967d\u592a\u90ce\u3000\u300c\u5f53\u9662\u306b\u304a\u3051\u308b\u751f\u7269\u5b66\u7684\u88fd\u5264\u306b\u3088\u308b\u30a2\u30c8\u30d4\u30fc\u6027\u76ae\u819a\u708e\u306e\u6cbb\u7642\u7d4c\u9a13\u300d\u3000
\u5bae\u5d0e\u770c\u76ae\u819a\u79d1\u533b\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a\u30002020.9\u3000\u5bae\u5d0e\u5e02<\/p>\n

2)\u5929\u91ce \u6b63\u5b8f\u3000\u300cATLL\u76ae\u819a\u75c5\u5909\u306e\u9451\u5225\u3068\u6cbb\u7642\u300d\u3000\u76ae\u819a\u75be\u60a3\u8a3a\u7642\u30b9\u30ad\u30eb\u30a2\u30c3\u30d7\u3000web\u3000seminar\u30002020.10\u3000WEB<\/p>\n

3)\u6210\u7530 \u5e78\u4ee3\u3000\u300c\u5f53\u79d1\u306b\u304a\u3051\u308b\u30b9\u30ad\u30ea\u30fc\u30b8\u4f7f\u7528\u4f8b\u300d\u3000\u5bae\u5d0e\u708e\u75c7\u6027\u76ae\u819a\u75be\u60a3\u30bb\u30df\u30ca\u30fc\u30002020.10\u3000\u5bae\u5d0e\u5e02<\/p>\n

\u305d\u306e\u4ed6<\/h1>\n

1)\u5929\u91ce \u6b63\u5b8f\u3000\u5f53\u79d1\u3067\u884c\u3063\u3066\u3044\u308b\u5275\u50b7\u6cbb\u7642\uff5e\u71b1\u50b7\u304b\u3089\u8925\u7621\u3001\u4e0b\u817f\u6f70\u760d\u307e\u3067\uff5e.
\u7b2c142\u56de\u3000\u5bae\u5d0e\u770c\u76ae\u819a\u79d1\u61c7\u8a71\u4f1a. \u5bae\u5d0e\u5e02 (2020\u5e742\u6708)<\/p>\n

2)\u5929\u91ce \u6b63\u5b8f\u3000\u76ae\u819aT\u7d30\u80de\u30ea\u30f3\u30d1\u816b\uff08CTCL\uff09\uff0d\u76ae\u819a\u75c5\u5909\u306e\u9451\u5225\u3068\u6cbb\u7642\uff0d.
\u591a\u6469\u5730\u533a\u76ae\u819a\u75be\u60a3\u5b66\u8853\u30bb\u30df\u30ca\u30fc. \u6771\u4eac (2020\u5e742\u6708)<\/p>\n

3)\u5929\u91ce \u6b63\u5b8f\u3000\u7b2c2\u56deBexarotane Investigator Meeting
\u75c7\u4f8b\u5831\u544a\u2460\uff1a\u5bae\u5d0e\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662 \uff082020\u5e747\u670811\u65e5\uff09
<\/span><\/p>\n

4)\u5929\u91ce \u6b63\u5b8f\u3000\u6210\u4ebaT\u7d30\u80de\u767d\u8840\u75c5\/\u30ea\u30f3\u30d1\u816b\uff08ATLL\uff09\uff0d\u4e7e\u766c\u3068\u306e\u985e\u4f3c\u6027\u3068\u9451\u5225\u306b\u3064\u3044\u3066\uff0d.
\u7b2c229\u56de\u3000\u65e5\u672c\u76ae\u819a\u79d1\u5b66\u4f1a\u718a\u672c\u5730\u65b9\u4f1a\u3000\u30e9\u30f3\u30c1\u30e7\u30f3\u30bb\u30df\u30ca\u30fc \uff082020\u5e7410\u67084\u65e5\uff09<\/p>\n

5)\u5927\u5cf6 \u5b5d\u4e00, \u5929\u91ce \u6b63\u5b8f, \u6ff1\u7530 \u5229\u4e45\u3000\u75c5\u7406\u306e\u5bfa\u5b50\u5c4b\u30b7\u30ea\u30fc\u30ba\u7b2c8\u56de\u3000
\u30bb\u30b6\u30ea\u30fc\u75c7\u5019\u7fa4\u3001\u7d05\u76ae\u75c7\u578b\u83cc\u72b6\u606f\u8089\u75c7\u3001\u7d05\u76ae\u75c7\u578bATL\u306e\u9451\u5225\u8a3a\u65ad\uff08\u75c5\u7406\u3001\u81e8\u5e8a\uff09 \uff082020\u5e7410\u670816\u65e5\uff09<\/p>\n","protected":false},"excerpt":{"rendered":"\u8457\u66f8 1)\u5929\u91ce \u6b63\u5b8f\u3000\u7dcf\u7de8\u96c6\uff1a\u5c71\u53e3 \u5fb9\u30fb\u4ed6\u76e3\u3000\u81bf\u76ae\u75c7 pyoderma\u4eca\u65e5\u306e\u6cbb\u7642\u6307\u91dd 2020\u5e74\u7248 \u79c1\u306f\u3053\u3046\u6cbb\u7642\u3057\u3066\u3044\u308b\uff08\u30c7\u30b9\u30af\u7248\u3001\u30dd\u30b1\u30c3\u30c8\u7248\uff09 \u533b\u5b66\u66f8\u96622020\u5e741\u6708 2)\u5929\u91ce \u6b63\u5b8f\u3000\u51fa\u5149 \u4fca\u90ce\uff0c\u795e\u90e8 \u82b3\u5247 \u7de8\u96c6 \u53e3\u8154","protected":false},"author":98,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_mi_skip_tracking":false},"categories":[9],"tags":[],"_links":{"self":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/derma\/wp-json\/wp\/v2\/posts\/1067"}],"collection":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/derma\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/derma\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/derma\/wp-json\/wp\/v2\/users\/98"}],"replies":[{"embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/derma\/wp-json\/wp\/v2\/comments?post=1067"}],"version-history":[{"count":4,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/derma\/wp-json\/wp\/v2\/posts\/1067\/revisions"}],"predecessor-version":[{"id":1198,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/derma\/wp-json\/wp\/v2\/posts\/1067\/revisions\/1198"}],"wp:attachment":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/derma\/wp-json\/wp\/v2\/media?parent=1067"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/derma\/wp-json\/wp\/v2\/categories?post=1067"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/derma\/wp-json\/wp\/v2\/tags?post=1067"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}